In addition, oral CLA administration significantly down-regulated colonic COX-2 expression (Figure 5B) whereas VSL#3 treatment upregulated angiostatin mRNA levels in the distal colon (Figure 5D), a proteolytic fragment of plasminogen with anti-angiogenic effects in mice with CRC. This evidence concerns the gene PTGS2 and colorectal carcinoma.